Vimarsana
Biggest News Aggregation in the World

Page 2 - Steph Mountifield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steph Mountifield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steph Mountifield Today - Breaking & Trending Today

GSK : Jemperli (dostarlimab) plus Zejula (niraparib) combination significantly improved progression-free survival in primary advanced or recurrent endometrial cancer in RUBY Part 2 Phase III trial - Form 6-K -December 18, 2023 at 06:38 am EST - Vimarsana News

GSK : Jemperli (dostarlimab) plus Zejula (niraparib) combination significantly improved progression-free survival in primary advanced or recurrent endometrial cancer in RUBY Part 2 Phase III trial - Form 6-K -December 18, 2023 at 06:38 am EST

Published: December 18, 2023

A1192x UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...

Source: marketscreener.com
Related Topics:
United Kingdom GeneralUnited KingdomTreasure IslandUnited StatesCity OfJames DodwellTim FoleyCamilla CampbellJeff MclaughlinMick ReadeyDan SmithHesham AbdullahJosh WilliamsLyndsay MeyerSteph MountifieldKathleen QuinnNick StoneEuropean Society Of Gynaecological OncologyCommission File NumberSecurities ExchangeEuropean Network Of Gynaecological Oncological TrialKantar HealthAnaptysbio IncTesaro IncInternational Research On Cancer
GSK : Japan's Ministry of Health, Labour and Welfare accepts Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk - Form 6-K -December 12, 2023 at 06:09 am EST - Vimarsana News

GSK : Japan's Ministry of Health, Labour and Welfare accepts Arexvy regulatory application to prevent RSV disease in adults aged 50-59 at increased risk - Form 6-K -December 12, 2023 at 06:09 am EST

Published: December 12, 2023

A3878w UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...

Source: marketscreener.com
Related Topics:
United StatesCity OfUnited KingdomUnited Kingdom GeneralSteph MountifieldCamilla CampbellJosh WilliamsTim FoleyRichard Osei YeboahSimon MooreJ Clin VirolJeff MclaughlinMick ReadeyNick StoneJames DodwellKathleen QuinnJapan Ministry Of HealthAdvisory Committee On Immunization PracticesAntigenics IncSecurities ExchangeUs Centers For DiseaseCenters For DiseaseAgenus IncSaponiqx IncCommission File Number
GSK : Phase III RUBY trial of Jemperli (dostarlimab) plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer - Form 6-K -October 30, 2023 at 07:13 am EDT - Vimarsana News

GSK : Phase III RUBY trial of Jemperli (dostarlimab) plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer - Form 6-K -October 30, 2023 at 07:13 am EDT

Published: October 30, 2023

A6268r UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...

Source: marketscreener.com
Related Topics:
United KingdomUnited StatesCity OfTreasure IslandUnited Kingdom GeneralNick StoneTim FoleyCamilla CampbellMick ReadeyJames DodwellSteph MountifieldKathleen QuinnJeff MclaughlinLyndsay MeyerDan SmithJosh WilliamsHesham AbdullahEuropean UnionSecurities ExchangeAnaptysbio IncTesaro IncKantar HealthInternational Research On CancerCommission File NumberFile Number
GSK : ViiV Healthcare receives approval from China's National Medical Products Administration (NMPA) for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine), the first and only complete long-acting HIV-1 injectable treatment - Form 6-K -October 26, 2023 at 08:20 am EDT - Vimarsana News

GSK : ViiV Healthcare receives approval from China's National Medical Products Administration (NMPA) for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine), the first and only complete long-acting HIV-1 injectable treatment - Form 6-K -October 26, 2023 at 08:20 am EDT

Published: October 26, 2023

A3337rgskplcedgar UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,...

Source: marketscreener.com
Related Topics:
United KingdomUnited StatesNorth CarolinaCity OfYong JunUnited Kingdom GeneralCamilla CampbellJeff MclaughlinDeborah WaterhouseSteph MountifieldMick ReadeyLyndsay MeyerNick StoneJames DodwellNicola AndreSarah ClementsAudrey AbernathyRachel JaikaranTim FoleyJosh WilliamsKathleen QuinnCommission File NumberSecurities ExchangeJanssen Pharmaceutical Companies Of Johnson RekambysChina National Medical Products Administration
GSK : THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION - Form 6-K -October 06, 2023 at 02:22 pm EDT - Vimarsana News

GSK : THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION - Form 6-K -October 06, 2023 at 02:22 pm EDT

Published: October 6, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER...

Source: marketscreener.com
Related Topics:
United KingdomUnited StatesUnited Kingdom GeneralCity OfTim FoleyNick StoneKathleen QuinnCamilla CampbellMick ReadeySarah ClementsJames DodwellLyndsay MeyerSteph MountifieldJeff MclaughlinJosh WilliamsSecurities ExchangePrudential Regulation AuthorityPrudential Regulatory AuthorityFinancial ServicesCitigroup Global Markets Limited CitiPfizer IncEuropean Union WithdrawalFinancial Conduct AuthorityCompany Annual Report On FormCommission File Number